-
Ryuichi KATO
-
David E. CASE
-
Hideo HAKUSUI
-
Kosei NODA
-
Fumio SAGAMI
-
Ikuo HORII
-
Hiroshi MAYAHARA
-
Mitchell N. CAYEN
-
Thomas B. MARRIOTT
-
Toshiji IGARASHI
-
Author's Organization:Department of Pharmacology, School of Medicine, Keio University Safety of Medicines Department, ZENECA Pharmaceuticals Developmental Research Laboratories, Daiichi Pharmaceutical Co., Ltd. Toxicology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd. Department of Safety Research, Eisai Co., Ltd. Department of Toxicology & Pathology, Nippon Roche Research Center Drug Safety Reserch Laboratories, Takeda Chemical Industry Department of Durg Metabolism and Pharmacokinetics, Schering-Plough Institute Clinical Investigation, McNeil Pharmaceutical, Spring House Department of R & D Information Technology, Eisai Co., Ltd.